Q4 25 EPS
$0.75
BEAT +4.15%
Est. $0.72
Q4 25 Revenue
$1.97B
MISS 2.09%
Est. $2.02B
vs S&P Since Q4 25
-3.3%
TRAILING MARKET
EMN +4.3% vs S&P +7.6%
Full Year 2025 Results
FY 25 EPS
$5.42
BEAT +0.63%
Est. $5.39
FY 25 Revenue
$8.75B
MISS 0.42%
Est. $8.79B
Market Reaction
Did EMN Beat Earnings? Q4 2025 Results
Eastman Chemical delivered a mixed fourth quarter for fiscal 2025, squeezing out a narrow earnings beat against a backdrop of sharply declining sales. The specialty materials company posted adjusted EPS of $0.75, edging past the $0.72 consensus estim… Read more Eastman Chemical delivered a mixed fourth quarter for fiscal 2025, squeezing out a narrow earnings beat against a backdrop of sharply declining sales. The specialty materials company posted adjusted EPS of $0.75, edging past the $0.72 consensus estimate by 4.17%, but revenue slid 12.1% year-over-year to $1.97 billion, falling short of the $2.01 billion analysts had expected. The primary culprit was a brutal combination of acetate tow destocking in the Fibers segment, which plunged 27%, and broad volume weakness across consumer discretionary end markets, with lower capacity utilization and pricing pressure from Asian competition compounding the damage in Chemical Intermediates. Full-year 2025 revenue declined 7% to $8.75 billion, prompting questions about the durability of Eastman's efficiency and sustainability strategy under persistent market headwinds. Management declined to issue a full-year 2026 EPS target citing macroeconomic uncertainty, but guided Q1 2026 adjusted EPS to $1.00 to $1.20, pointing to $125 million to $150 million in structural cost reductions and continued methanolysis growth as the primary engines of recovery.
Key Takeaways
- • Commercial excellence in defending product value amid weak economic environment
- • Cost reduction initiatives exceeded $100 million target versus goal of greater than $75 million
- • Lower sales volume/mix driven by customer inventory destocking in acetate tow and consumer discretionary weakness
- • Unfavorable price-cost dynamics partially offset by lower variable compensation expense
- • Increased competitive pressure from Asia impacting Chemical Intermediates pricing
- • Higher-than-usual seasonal demand declines as customers leveraged prepositioned inventory to mitigate tariff impacts
EMN YoY Financials
Q4 2025 vs Q4 2024, source: SEC Filings
EMN Revenue by Segment
With YoY comparisons, source: SEC Filings
EMN Revenue by Geography
With YoY comparisons, source: SEC Filings
“Despite a challenging operating environment for the chemical industry and continued weakness in consumer discretionary end markets, our team delivered a year that demonstrates the strength of our portfolio's ability to generate cash. In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management. Our commercial teams showed excellence in defending the value of our products, and we accelerated our structural cost reductions throughout the year to protect margins and preserve competitiveness.”
— Mark Costa, Q4 2025 Earnings Press Release
EMN Earnings Trends
EMN vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
EMN EPS Trend
Earnings per share: estimate vs actual
EMN Revenue Trend
Quarterly revenue: estimate vs actual
EMN Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.06 | $1.09 | +2.42% | $2.18B | -0.06% |
| Q4 25 BEAT FY | $0.72 | $0.75 | +4.15% | $1.97B | -2.09% |
| FY Full Year | $5.39 | $5.42 | +0.63% | $8.75B | -0.42% |
| Q3 25 MISS | $1.17 | $1.14 | -2.16% | $2.20B | -3.23% |
| Q2 25 MISS | $1.75 | $1.60 | -8.71% | $2.29B | -0.75% |
| Q1 25 BEAT | $1.89 | $1.91 | +1.22% | $2.29B | -1.72% |